Evaluating the role of intra articular injection of platelet‐rich fibrin in the management of temporomandibular joint osteoarthritis: A STROBE compliant retrospective study

Bera, Rathindra Nath; Tiwari, Preeti

doi:10.1111/ors.12665

Cited by 2 publications

(2 citation statements)

References 27 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…75 In another study, the effects of intra-articular i-PRF injections on the treatment of osteoarthritis of the TMJ were assessed. 76 In this study, it was revealed that while i-PRF did not alleviate TMJ pain after 6 months, repeated injections did positively impact maximal mouth opening. Ghoneim and colleagues also compared the effectiveness of arthrocentesis with/without i-PRF injections for the treatment of TMJ disc displacement and reduction.…”

Section: Clini C Al Us E Of I-prf For Tmj Injec Tionsmentioning

confidence: 65%

“…At the 3‐month follow‐up, substantial improvements in VAS and Helkimo clinical dysfunction scores were reported, along with improvements in the maximum incisal opening of the patients 75 . In another study, the effects of intra‐articular i‐PRF injections on the treatment of osteoarthritis of the TMJ were assessed 76 . In this study, it was revealed that while i‐PRF did not alleviate TMJ pain after 6 months, repeated injections did positively impact maximal mouth opening.…”

Section: Clinical Use Of I‐prf For Tmj Injectionsmentioning

confidence: 99%

See 1 more Smart Citation

Ten years of injectable platelet‐rich fibrin

Miron,

Gruber,

Farshidfar

et al. 2023

Periodontology 2000

View full text Add to dashboard Cite

The use of platelet‐rich fibrin (PRF) has seen widespread advantages over platelet‐rich plasma (PRP) in many fields of medicine. However, until 2014, PRF remained clinically available only in its solid clotted form. Modifications to centrifugation protocols and tube technology have led to the development of a liquid injectable version of PRF (i‐PRF). This narrative review takes a look back at the technological developments made throughout the past decade and further elaborates on their future clinical applications. Topics covered include improvements in isolation techniques and protocols, ways to further concentrate i‐PRF, and the clinical impact and relevance of cooling i‐PRF. Next, various uses of i‐PRF are discussed, including its use in regenerative periodontology, implantology, endodontics, temporomandibular joint injections, and orthodontic tooth movement. Furthermore, various indications in medicine are also covered, including its use in sports injuries and osteoarthritis of various joints, treatment of diabetic ulcers/wound care, and facial esthetics and hair regrowth. Finally, future applications are discussed, mainly its use as a drug delivery vehicle for small biomolecules, such as growth factors, antibiotics, exosomes, and other medications that may benefit from the controlled and gradual release of biomolecules over time.

show abstract

Section: Clini C Al Us E Of I-prf For Tmj Injec Tionsmentioning

confidence: 65%

Section: Clinical Use Of I‐prf For Tmj Injectionsmentioning

confidence: 99%

Ten years of injectable platelet‐rich fibrin

Miron,

Gruber,

Farshidfar

et al. 2023

Periodontology 2000

View full text Add to dashboard Cite

show abstract

Current Clinical Research Directions on Temporomandibular Joint Intra-Articular Injections: A Mapping Review

Chęciński¹,

Chęcińska

Turosz

et al. 2023

JCM

View full text Add to dashboard Cite

This mapping review aims to identify and discuss current research directions on intracavitary temporomandibular joints (TMJs) injections. The inclusion criteria allowed studies published in the last full six years, based on patients diagnosed with temporomandibular joint disorders (TMDs), treated by TMJ intra-articular injections. Medical databases covered by the Association for Computing Machinery, Bielefeld Academic Search Engine, PubMed, and Elsevier Scopus engines were searched. The results were visualized with tables, charts, and diagrams. Of the 2712 records identified following the selection process, 152 reports were qualified for review. From January 2017, viscosupplementation with hyaluronic acid (HA) was the best-documented injectable administered into TMJ cavities. However, a significant growing trend was observed in the number of primary studies on centrifuged blood preparations administrations that surpassed the previously leading HA from 2021.

show abstract

Evaluating the role of intra articular injection of platelet‐rich fibrin in the management of temporomandibular joint osteoarthritis: A STROBE compliant retrospective study

Cited by 2 publications

References 27 publications

Ten years of injectable platelet‐rich fibrin

Ten years of injectable platelet‐rich fibrin

Current Clinical Research Directions on Temporomandibular Joint Intra-Articular Injections: A Mapping Review

Contact Info

Product

Resources

About